Literature DB >> 15481608

Relationship of hemodynamic indices and prognosis in patients with liver cirrhosis.

Soon Koo Baik1, Myeong Gwan Jee, Phil Ho Jeong, Jae Woo Kim, Sang Won Ji, Hyun Soo Kim, Dong Ki Lee, Sang Ok Kwon, Young Ju Kim, Joong Wha Park, Sei Jin Chang.   

Abstract

BACKGROUND: Hyperdynamic circulation due to reduced peripheral vascular resistance and increased cardiac output, and the development of portal hypertension are the hemodynamic changes observed in patients with liver cirrhosis. Such hemodynamic abnormalities appear in patients with late stage liver cirrhosis. Therefore, hemodynamic indices, which represent hyperdynamic circulation and portal hypertension, are significant for the prognosis of patients with liver cirrhosis. The aim of this study was to determine the hemodynamic indices associated with the prognosis of patients with liver cirrhosis.
METHODS: A total of 103 patients diagnosed with liver cirrhosis between December 1999 and June 2003, with a mean follow-up period of 73 weeks, ranging from 7 to 168 weeks, were recruited. Using Child-Pugh classification, the mean arterial pressure, heart rate and hepatic venous pressure gradient (HVPG) were measured. The indices of Doppler ultrasonography, including the portal and splenic venous flows, and the resistance of the hepatic, splenic, and renal arteries were also measured using the arterial pulsatility index (PI). The prognostic values of these indices were determined by their comparison with the patient survivals.
RESULTS: Significant hemodynamic indices for a bad prognosis were high HVPG (> or = 15 mmHg) and renal arterial PI (> or = 1.14)(p<0.05). A Child-Pugh score > or = 10 was important for a poor prognosis (p<0.05).
CONCLUSION: Severe portal hypertension (HVPG > or = 15 mmHg) and high renal arterial resistance (PI +/- 1.14) were valuable hemodynamic indices for the prognosis of patients with liver cirrhosis. Therefore, it was concluded that the measurement of these hemodynamic indices, in addition to the Child-Pugh classification, is helpful in the prognosis of patients with liver cirrhosis.

Entities:  

Mesh:

Year:  2004        PMID: 15481608      PMCID: PMC4531557          DOI: 10.3904/kjim.2004.19.3.165

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  19 in total

1.  MELD and PELD: application of survival models to liver allocation.

Authors:  R H Wiesner; S V McDiarmid; P S Kamath; E B Edwards; M Malinchoc; W K Kremers; R A Krom; W R Kim
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799

2.  Hemodynamic imaging with pulsatility-index and resistive-index color Doppler US.

Authors:  G S Lin; R S Spratt
Journal:  Radiology       Date:  1997-09       Impact factor: 11.105

3.  Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension.

Authors:  A Escorsell ; J C Bandi; V Andreu; E Moitinho; J C García-Pagán; J Bosch; J Rodés
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

4.  Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion.

Authors:  V Arroyo; R Planas; J Gaya; R Deulofeu; A Rimola; R M Pérez-Ayuso; F Rivera; J Rodés
Journal:  Eur J Clin Invest       Date:  1983-06       Impact factor: 4.686

5.  Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure.

Authors:  A W Schneider; J F Kalk; C P Klein
Journal:  J Hepatol       Date:  1999-05       Impact factor: 25.083

Review 6.  Pathophysiology of portal hypertension and variceal bleeding.

Authors:  T C Mahl; R J Groszmann
Journal:  Surg Clin North Am       Date:  1990-04       Impact factor: 2.741

Review 7.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

8.  Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.

Authors:  B Angermayr; M Cejna; F Karnel; M Gschwantler; F Koenig; J Pidlich; H Mendel; L Pichler; M Wichlas; A Kreil; M Schmid; A Ferlitsch; E Lipinski; H Brunner; J Lammer; P Ferenci; A Gangl; M Peck-Radosavljevic
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

9.  Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.

Authors:  Soon Koo Baik; Dong Hun Park; Moon Young Kim; Yeun Jong Choi; Hyun Soo Kim; Dong Ki Lee; Sang Ok Kwon; Young Ju Kim; Joong Wha Park; Sei Jin Chang
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

10.  Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography.

Authors:  D Sacerdoti; M Bolognesi; C Merkel; P Angeli; A Gatta
Journal:  Hepatology       Date:  1993-02       Impact factor: 17.425

View more
  12 in total

1.  Vascular Doppler ultrasonographic indices in cirrhosis: a case-control study with emphasis on the common carotid arteries.

Authors:  Abolhassan Shakeri; Mojtaba Varshochi; Naser Atapour; Masoud Nemati; Manoochehr Khoshbaten; Daniel Fadaei Fouladi
Journal:  Radiol Med       Date:  2015-03-01       Impact factor: 3.469

2.  Effect of propranolol on portal pressure and systemic hemodynamics in patients with liver cirrhosis and portal hypertension: a prospective study.

Authors:  Ki Tae Suk; Moon Young Kim; Dong Hun Park; Kyu Hong Kim; Ki Won Jo; Jin Hon Hong; Jae Woo Kim; Hyun Soo Kim; Sang Ok Kwon; Soon Koo Baik
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

3.  Doppler waveform study as indicator of change of portal pressure after administration of octreotide.

Authors:  Shahbaz Haider; Qurban Hussain; Sumera Tabassum; Bilal Hussain; Muhammad Rasheed Durrani; Fayyaz Ahmed
Journal:  Pak J Med Sci       Date:  2016 Jul-Aug       Impact factor: 1.088

4.  Association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function.

Authors:  Wei Wang; Jiye Li; Runhua Pan; Sileng A; Caixian Liao
Journal:  Hepatol Int       Date:  2015-07-25       Impact factor: 6.047

5.  Level and Value of T Cell-derived Circulating Microparticles in Liver Cirrhosis Patients.

Authors:  Chih-Hung Chen; Chia-Lo Chang; Kuan-Hung Chen; Ben-Chung Cheng; Hong-Hwa Chen; John Y Chiang; Pei-Hsun Sung; Hon-Kan Yip
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

6.  Levels and values of circulating endothelial progenitor cells, soluble angiogenic factors, and mononuclear cell apoptosis in liver cirrhosis patients.

Authors:  Chih-Hung Chen; Li-Teh Chang; Wei-Chih Tung; Yung-Lung Chen; Chia-Lo Chang; Steve Leu; Cheuk-Kwan Sun; Tzu-Hsien Tsai; I-Ting Tsai; Hsueh-Wen Chang; Hon-Kan Yip
Journal:  J Biomed Sci       Date:  2012-07-18       Impact factor: 8.410

7.  Doppler parameters of hepatic and renal hemodynamics in patients with liver cirrhosis.

Authors:  D Popov; R Krasteva; R Ivanova; L Mateva; Z Krastev
Journal:  Int J Nephrol       Date:  2012-07-03

8.  Impact of Propranolol on Preventing Renal Dysfunction in Patients with Cirrhosis.

Authors:  Kambiz Akhavan Rezayat; Abbas Ali Zeraati; Masoud Pezeshki Rad; Jalal Chogan; Najmeh Davoudian; Amir Akhavan Rezayat; Seyed Mousalreza Hoseini
Journal:  Middle East J Dig Dis       Date:  2017-10

9.  Bedside sublingual video imaging of microcirculation in assessing bacterial infection in cirrhosis.

Authors:  Muhammad Y Sheikh; Usman Javed; Jasjit Singh; Jayanta Choudhury; Omer Deen; Kulraj Dhah; Michael W Peterson
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

10.  Correlation of HVPG level with ctp score, MELD Score, ascites, size of varices, and etiology in cirrhotic patients.

Authors:  Subramaniam Ramanathan; Niranjan Khandelwal; Naveen Kalra; Anmol Bhatia; Radha K Dhiman; Ajay K Duseja; Yogesh K Chawla
Journal:  Saudi J Gastroenterol       Date:  2016 Mar-Apr       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.